GenInsole: A highly customised therapeutic insole for early diagnosis of diabetic foot ulcers
More than 738 million individuals will have diabetes by 2045, of which 15-34% of them are likely to develop diabetic foot ulcers. GenInsole provides an innovative solution through the design of a highly customised therapeutic insole. The customised insoles can enhance comfort and functionality through an effective foot plantar pressure redistribution.
About the project
Diabetes is a global public health issue. The International Diabetes Federation estimate that more than 738 million individuals will have diabetes by 2045, of which 15-34% of them are likely to develop diabetic foot ulcers (DFUs) during their lifetime. Clinical evidence suggests that preventative care and improving diabetic foot care services can directly affect patient outcomes and reduce associated costs. Using appropriate insoles can reduce plantar pressure, leading to reduced occurrence of ulcers and improved quality of life. GenInsole provides an innovative solution in the design of a highly customised therapeutic insole. The customised insoles can enhance comfort and functionality through an effective foot plantar pressure redistribution. .